The Japanese Society for Cutaneous Immunology and Allergy (JSCIA), in partnership with Pfizer, invites proposals for initiatives aimed at improving the clinical environment for dermatologic immunology, inflammation and allergy care in Japan. The grant supports projects focusing on cutaneous immune-mediated, inflammatory, and allergic diseases that contribute to continuous improvement of healthcare quality: standardizing clinical practices
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: